After the WES of 34 HCC patients, we found that DPHCC patients exhibited a higher frequency of gene and pathway mutations than CK19-HCC patients, indicating that abnormal PI3K-Akt signaling may be an inherent characteristic of DPHCC. The gene discussed is AKT1; the disease is hepatocellular carcinoma.